Griffin Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.7M | Sell |
78,095
-630
| -0.8% | -$136K | 2.07% | 8 |
|
|
2026
Q1 | $17.1M | Sell |
78,725
-2,204
| -3% | -$489K | 1.93% | 11 |
|
|
2025
Q4 | $18.5M | Buy |
80,929
+734
| +0.9% | +$167K | 2% | 10 |
|
|
2025
Q3 | $18.6M | Buy |
80,195
+60
| +0.1% | +$12.2K | 2.09% | 7 |
|
|
2025
Q2 | $14.9M | Sell |
80,135
-1,411
| -2% | -$262K | 1.76% | 11 |
|
|
2025
Q1 | $17.1M | Sell |
81,546
-110
| -0.1% | -$21.4K | 2.09% | 6 |
|
|
2024
Q4 | $14.5M | Buy |
81,656
+1,074
| +1% | +$197K | 1.71% | 12 |
|
|
2024
Q3 | $15.9M | Sell |
80,582
-2,946
| -4% | -$550K | 1.78% | 6 |
|
|
2024
Q2 | $14.3M | Buy |
83,528
+74
| +0.1% | +$12.3K | 1.66% | 9 |
|
|
2024
Q1 | $15.2M | Sell |
83,454
-5,896
| -7% | -$1.02M | 1.81% | 7 |
|
|
2023
Q4 | $13.8M | Sell |
89,350
-193
| -0.2% | -$28.1K | 1.76% | 7 |
|
|
2023
Q3 | $13.3M | Buy |
89,543
+20
| +0% | +$2.94K | 1.9% | 5 |
|
|
2023
Q2 | $12.1M | Buy |
89,523
+1,526
| +2% | +$224K | 1.63% | 8 |
|
|
2023
Q1 | $14M | Sell |
87,997
-823
| -0.9% | -$126K | 1.96% | 4 |
|
|
2022
Q4 | $14.4M | Buy |
88,820
+2,551
| +3% | +$391K | 2.16% | 4 |
|
|
2022
Q3 | $11.6M | Sell |
86,269
-431
| -0.5% | -$61.8K | 1.92% | 5 |
|
|
2022
Q2 | $13.3M | Sell |
86,700
-7,643
| -8% | -$1.17M | 2.12% | 6 |
|
|
2022
Q1 | $15.3M | Sell |
94,343
-14,063
| -13% | -$2.04M | 1.98% | 5 |
|
|
2021
Q4 | $14.7M | Buy |
108,406
+4,965
| +5% | +$586K | 1.82% | 7 |
|
|
2021
Q3 | $11.2M | Sell |
103,441
-4,600
| -4% | -$526K | 1.43% | 14 |
|
|
2021
Q2 | $12.2M | Buy |
108,041
+202
| +0.2% | +$22.8K | 1.47% | 9 |
|
|
2021
Q1 | $11.7M | Buy |
107,839
+2,063
| +2% | +$221K | 1.49% | 8 |
|
|
2020
Q4 | $11.3M | Buy |
105,776
+4,946
| +5% | +$475K | 1.5% | 8 |
|
|
2020
Q3 | $8.83M | Sell |
100,830
-20,803
| -17% | -$1.96M | 1.36% | 12 |
|
|
2020
Q2 | $11.9M | Buy |
121,633
+4,775
| +4% | +$420K | 1.91% | 6 |
|
|
2020
Q1 | $8.9M | Buy |
116,858
+40
| +0% | +$3.41K | 1.69% | 9 |
|
|
2019
Q4 | $10.3M | Buy |
116,818
+659
| +0.6% | +$54.7K | 1.45% | 8 |
|
|
2019
Q3 | $8.8M | Buy |
116,159
+649
| +0.6% | +$44.5K | 1.37% | 11 |
|
|
2019
Q2 | $8.4M | Buy |
115,510
+1,976
| +2% | +$155K | 1.07% | 18 |
|
|
2019
Q1 | $9.15M | Sell |
113,534
-16,189
| -12% | -$1.32M | 1.29% | 14 |
|
|
2018
Q4 | $12M | Buy |
129,723
+5,816
| +5% | +$511K | 2.02% | 6 |
|
|
2018
Q3 | $11.7M | Buy |
123,907
+1,143
| +0.9% | +$108K | 1.72% | 10 |
|
|
2018
Q2 | $11.4M | Sell |
122,764
-2,030
| -2% | -$198K | 2.06% | 8 |
|
|
2018
Q1 | $11.8M | Sell |
124,794
-3,824
| -3% | -$420K | 2.15% | 7 |
|
|
2017
Q4 | $12.4M | Sell |
128,618
-20,289
| -14% | -$1.91M | 2.21% | 6 |
|
|
2017
Q3 | $13.2M | Buy |
148,907
+23,128
| +18% | +$1.76M | 2.39% | 4 |
|
|
2017
Q2 | $9.12M | Buy |
+125,779
| New | +$8.46M | 2.44% | 6 |
|
|
2015
Q4 | $7.49M | Sell |
126,364
-4,330
| -3% | -$249K | 3.15% | 5 |
|
|
2015
Q3 | $7.11M | Sell |
130,694
-1,517
| -1% | -$98.7K | 2.96% | 5 |
|
|
2015
Q2 | $8.88M | Sell |
132,211
-4,422
| -3% | -$289K | 3.41% | 4 |
|
|
2015
Q1 | $8M | Buy |
136,633
+7,297
| +6% | +$441K | 2.32% | 9 |
|
|
2014
Q4 | $8.46M | Sell |
129,336
-4,016
| -3% | -$253K | 2.25% | 11 |
|
|
2014
Q3 | $7.7M | Sell |
133,352
-9,329
| -7% | -$518K | 2.3% | 10 |
|
|
2014
Q2 | $8.05M | Buy |
142,681
+7,517
| +6% | +$394K | 2.52% | 7 |
|
|
2014
Q1 | $6.95M | Buy |
135,164
+1,128
| +0.8% | +$57K | 2.25% | 14 |
|
|
2013
Q4 | $7.08M | Buy |
134,036
+10,007
| +8% | +$492K | 2.29% | 13 |
|
|
2013
Q3 | $5.55M | Buy |
124,029
+1,022
| +0.8% | +$45.3K | 1.81% | 18 |
|
|
2013
Q2 | $5.08M | Buy |
+123,007
| New | +$5.38M | 1.84% | 19 |
|
Other funds holding ABBV
Griffin Asset Management's ABBV Position: Q2 2026 in Review
Griffin Asset Management reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $136K and leaving 78,095 shares worth $19.7M. The position accounts for 2.07% of the portfolio, ranked #8.
Griffin Asset Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Griffin Asset Management held 78,095 shares of AbbVie worth $19.7M as of Q2 2026.
- Griffin Asset Management sold 630 AbbVie shares in Q2 2026, an estimated $136K.
- AbbVie made up 2.07% of Griffin Asset Management's portfolio in Q2 2026, its #8 holding.
- Griffin Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.